Keywords
SARS-CoV-2, COVID-19, ARDS, pharmacology, treatment, therapeutic options, chloroquine, hydroxychloroquine, azithromycin, favipravir, umifenovir, protease inhibitor, Mpro, remdesivir, monoclonal antibodies